Graham Capital Management »

Inhibrx Biosciences shares owned by Graham Capital Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $352k 5.2k 67.23

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Amazon (AMZN)
Green Plains Note 5.250%11/0 (Principal)
Calumet Put Option (CLMT)
Sunrun Note 4.000% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
NVIDIA Corporation (NVDA)
The Realreal Debt 4.000% 2/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Vanguard Capital Management
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
State Street Corporation
Millennium Management

View all funds holding Inhibrx Biosciences